Deutsche Bank AG acquired a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 74,260 shares of the financial services provider's stock, valued at approximately $1,839,000. Deutsche Bank AG owned about 0.17% of Trupanion as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently bought and sold shares of TRUP. Polar Capital Holdings Plc lifted its stake in shares of Trupanion by 13.5% in the 4th quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider's stock worth $55,121,000 after purchasing an additional 175,000 shares during the period. State Street Corp grew its position in Trupanion by 2.2% during the fourth quarter. State Street Corp now owns 1,290,987 shares of the financial services provider's stock valued at $48,244,000 after buying an additional 27,385 shares during the period. Marshall Wace LLP grew its position in Trupanion by 4.5% during the fourth quarter. Marshall Wace LLP now owns 1,267,262 shares of the financial services provider's stock valued at $47,358,000 after buying an additional 55,111 shares during the period. Greenlea Lane Capital Management LLC increased its holdings in Trupanion by 1.6% during the fourth quarter. Greenlea Lane Capital Management LLC now owns 776,490 shares of the financial services provider's stock valued at $29,017,000 after buying an additional 12,395 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Trupanion by 15.7% in the first quarter. Dimensional Fund Advisors LP now owns 702,086 shares of the financial services provider's stock worth $17,981,000 after acquiring an additional 95,064 shares during the period.
Insider Transactions at Trupanion
In related news, EVP Steve Weinrauch sold 6,674 shares of the company's stock in a transaction on Friday, June 5th. The shares were sold at an average price of $22.00, for a total transaction of $146,828.00. Following the completion of the transaction, the executive vice president owned 78,062 shares in the company, valued at approximately $1,717,364. This represents a 7.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Margaret Tooth sold 978 shares of the firm's stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total transaction of $28,410.90. Following the transaction, the chief executive officer directly owned 175,401 shares of the company's stock, valued at $5,095,399.05. The trade was a 0.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 15,116 shares of company stock valued at $395,999. 5.58% of the stock is currently owned by corporate insiders.
Trupanion Stock Down 0.1%
TRUP opened at $29.62 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. Trupanion, Inc. has a fifty-two week low of $21.16 and a fifty-two week high of $46.98. The firm's fifty day moving average is $27.00 and its 200 day moving average is $26.00. The stock has a market cap of $1.30 billion, a price-to-earnings ratio of 55.89, a price-to-earnings-growth ratio of 2.00 and a beta of 1.39.
Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The business had revenue of $392.93 million during the quarter, compared to analyst estimates of $389.72 million. During the same quarter in the prior year, the business posted $0.22 EPS. Trupanion's revenue for the quarter was up 11.1% compared to the same quarter last year. On average, sell-side analysts forecast that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on TRUP shares. Stifel Nicolaus boosted their price objective on shares of Trupanion from $28.00 to $29.00 and gave the company a "hold" rating in a research report on Thursday, August 20th. Piper Sandler cut Trupanion from an "overweight" rating to a "neutral" rating and decreased their target price for the stock from $45.00 to $32.00 in a report on Wednesday. Zacks Research downgraded Trupanion from a "strong-buy" rating to a "hold" rating in a research report on Monday, August 24th. Weiss Ratings raised Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a report on Wednesday. Finally, Atlantic Securities set a $42.00 price target on Trupanion in a research report on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $39.20.
Get Our Latest Analysis on TRUP
Trupanion Company Profile
(
Free Report)
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Stories
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report